Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Vanda Pharmaceuticals Inc. (VNDA) had Receiveable Turnover of 5.64 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$192.64M |
|
$2.51M |
|
$14.80M |
|
$177.84M |
|
$206.59M |
|
$-13.95M |
|
$20.29M |
|
$6.34M |
|
$6.34M |
|
$2.51M |
|
$2.51M |
|
$2.51M |
|
$2.51M |
|
$-13.95M |
|
$-19.74M |
|
57.38M |
|
57.56M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$432.95M |
|
$2.04M |
|
$215.49M |
|
$648.44M |
|
$87.70M |
|
-- |
|
$15.83M |
|
$103.53M |
|
$544.91M |
|
$423.54M |
|
$544.91M |
|
57.53M |
|
| Cash Flow Statement Financials | |
$12.80M |
|
$-12.06M |
|
$0.00M |
|
$135.50M |
|
$136.29M |
|
$0.79M |
|
$14.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.32% |
|
-7.24% |
|
-7.24% |
|
-10.25% |
|
3.29% |
|
1.30% |
|
$-88.25M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
10.90 |
|
|
Receiveable Turnover |
5.64 |
64.71 |
|
0.46% |
|
0.59% |
|
0.39% |
|
0.46% |
|
$9.47 |
|
$-1.53 |
|
$0.22 |
|